 Subjects -> PATENTS, TRADEMARKS AND COPYRIGHTS (Total: 29 journals)
|
|
|
- GPR119 agonists for the treatment of type 2 diabetes: an updated patent
review (2014-present)- Authors: Huilan Li, Yuanying Fang, Shuchun Guo, Zunhua Yang
Pages: 1 - 14
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-05-10T05:47:14Z
DOI: 10.1080/13543776.2021.1921152
- An updated patent review of Akt inhibitors (2016-present)
- Authors: Yu Guo, Yizhen Jin, Bingxue Qu, Yu Zhang, Jinxin Che, Xiaowu Dong
Pages: 1 - 13
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-05-02T03:53:40Z
DOI: 10.1080/13543776.2021.1915291
- A patent review of topoisomerase I inhibitors (2016–present)
- Authors: Asier Selas, Endika Martin-Encinas, Maria Fuertes, Carme Masdeu, Gloria Rubiales, Francisco Palacios, Concepción Alonso
Pages: 1 - 36
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-04-29T07:04:28Z
DOI: 10.1080/13543776.2021.1879051
- Steroid sulfatase inhibitors: the current landscape
- Authors: Hanan S. Anbar, Zahraa Isa, Jana J. Elounais, Mariam A. Jameel, Joudi H. Zib, Aya M. Samer, Aya F. Jawad, Mohammed I. El-Gamal
Pages: 1 - 20
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-04-19T12:51:45Z
DOI: 10.1080/13543776.2021.1910237
- Synthesis and therapeutic delivery approaches for praziquantel: a patent
review (2010-present)- Authors: Tayo A. Adekiya, Pradeep Kumar, Pierre P.D. Kondiah, Viness Pillay, Yahya E. Choonara
Pages: 1 - 15
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-04-19T08:39:10Z
DOI: 10.1080/13543776.2021.1915292
- Patent landscape of pediatric-friendly oral dosage forms and
administration devices- Authors: Christina Karavasili, Angelos Gkaragkounis, Dimitrios G. Fatouros
Pages: 1 - 23
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-04-19T07:45:33Z
DOI: 10.1080/13543776.2021.1893691
- Inhibitors of prostate-specific membrane antigen in the diagnosis and
therapy of metastatic prostate cancer – a review of patent literature- Authors: Hyunsoo Ha, Hongmok Kwon, Taehyeong Lim, Jaebong Jang, Song-Kyu Park, Youngjoo Byun
Pages: 1 - 23
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-04-16T07:46:23Z
DOI: 10.1080/13543776.2021.1878145
- Aurora kinase inhibitors: a patent review (2014-2020)
- Authors: Xue-Li Jing, Shi-Wu Chen
Pages: 1 - 19
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-04-13T12:26:58Z
DOI: 10.1080/13543776.2021.1890027
- Synthetic molecules as DprE1 inhibitors: A patent review
- Authors: Mohd. Imran, Alshrari A.S., Hamdy Kh. Thabet, Abida, Md. Afroz Bakht
Pages: 1 - 14
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-04-13T07:28:17Z
DOI: 10.1080/13543776.2021.1902990
- Negative allosteric modulators of group II metabotropic glutamate
receptors: A patent review (2015 – present)- Authors: Alshaima’a M. Qunies, Kyle A. Emmitte
Pages: 1 - 22
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-03-31T09:47:50Z
DOI: 10.1080/13543776.2021.1903431
- Recent progress in small molecule TBK1 inhibitors: a patent review
(2015– 2020)- Authors: Douglas W. Thomson, Giovanna Bergamini
Pages: 1 - 10
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-03-31T09:08:02Z
DOI: 10.1080/13543776.2021.1904893
- Visible light-curable water-soluble chitosan derivative, chitosan
hydrogel, and preparation method: a patent evaluation of US2019202998A1- Authors: Thashree Marimuthu, Pradeep Kumar, Yahya E. Choonara
Pages: 1 - 10
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-03-30T08:46:51Z
DOI: 10.1080/13543776.2021.1903433
- Phosphoglycerate dehydrogenase (PHGDH) inhibitors: a comprehensive review
2015–2020- Authors: Quentin Spillier, Raphaël Frédérick
Pages: 1 - 12
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-03-29T01:57:06Z
DOI: 10.1080/13543776.2021.1890028
- TRPV4 antagonists: a patent review (2015–2020)
- Authors: Brian G. Lawhorn, Edward J. Brnardic, David J. Behm
Pages: 1 - 12
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-03-24T01:08:53Z
DOI: 10.1080/13543776.2021.1903432
- Thioredoxin reductase inhibitors: updated patent review (2017-present)
- Authors: Evgeny Chupakhin, Mikhail Krasavin
Pages: 1 - 14
Abstract: .
Citation: Expert Opinion on Therapeutic Patents
PubDate: 2021-03-22T07:37:02Z
DOI: 10.1080/13543776.2021.1899160
- Recent development in the discovery of PARP inhibitors as anticancer
agents: a patent update (2016-2020)- .
Expert Opinion on Therapeutic Patents2021-03-12T08:32:48Z
DOI: 10.1080/13543776.2021.1886275
- Tankyrase inhibitors as antitumor agents: a patent update (2013 –
2020)- .
Expert Opinion on Therapeutic Patents2021-03-02T08:13:46Z
DOI: 10.1080/13543776.2021.1888929
- Agonist of stimulator of interferon genes as antitumor agents: a patent
review (2008-2020)- .
Expert Opinion on Therapeutic Patents2021-03-02T04:37:30Z
DOI: 10.1080/13543776.2021.1877660
- Novel matrix metalloproteinase inhibitors: an updated patent review (2014
- 2020)- .
Expert Opinion on Therapeutic Patents2021-02-22T12:13:17Z
DOI: 10.1080/13543776.2021.1881481
- Small molecule DNA-PK inhibitors as potential cancer therapy: a patent
review (2010–present)- .
Expert Opinion on Therapeutic Patents2021-02-10T08:46:22Z
DOI: 10.1080/13543776.2021.1866540
- Novel ligands and modulators of triggering receptor expressed on myeloid
cells receptor family: 2015-2020 updates- .
Expert Opinion on Therapeutic Patents2021-02-08T10:19:06Z
DOI: 10.1080/13543776.2021.1883587
- Hypoxia-inducible factor (HIF) inhibitors: a patent survey
(2016–2020)- .
Expert Opinion on Therapeutic Patents2021-01-29T05:55:37Z
DOI: 10.1080/13543776.2021.1874345
- Acetylcholinesterase inhibitors for the treatment of Alzheimer’s disease
– a patent review (2016–present)- .
Expert Opinion on Therapeutic Patents2021-01-14T05:17:21Z
DOI: 10.1080/13543776.2021.1874344
- An updated patent review of autotaxin inhibitors (2017–present)
- .
Expert Opinion on Therapeutic Patents2021-01-12T01:05:06Z
DOI: 10.1080/13543776.2021.1867106
- Therapeutic approaches targeting the neurotensin receptors
- .
Expert Opinion on Therapeutic Patents2021-01-08T03:21:29Z
DOI: 10.1080/13543776.2021.1866539
|
Hybrid journal (It can contain Open Access articles)
